{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T18:27:35Z","timestamp":1782325655489,"version":"3.54.5"},"reference-count":21,"publisher":"Department of Medicine, Warren Alpert Medical School at Brown University","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>\n                    Human granulocytic anaplasmosis is an emerging tick-borne illness caused by\n                    <jats:italic>Anaplasma phagocytophilum<\/jats:italic>\n                    and transmitted by Ixodes ticks. Clinical manifestations are often nonspecific, including fever, malaise, and cytopenias, which can delay recognition and treatment. Although thrombocytopenia is common in human granulocytic anaplasmosis (HGA), profound thrombocytopenia is rarely described, and cardiac conduction abnormalities remain infrequently reported. We describe a 73-year-old woman in New England who developed fever, somnolence, acute kidney injury, transaminitis, a platelet nadir of\n                    <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" display=\"inline\">\n                      <mml:mrow>\n                        <mml:mn>12<\/mml:mn>\n                        <mml:mo>\u00d7<\/mml:mo>\n                        <mml:msup>\n                          <mml:mn>10<\/mml:mn>\n                          <mml:mn>9<\/mml:mn>\n                        <\/mml:msup>\n                        <mml:mi>\/<\/mml:mi>\n                        <mml:mi>L<\/mml:mi>\n                        <mml:mrow>\n                          <mml:mo stretchy=\"true\" form=\"prefix\">(<\/mml:mo>\n                          <mml:mn>168<\/mml:mn>\n                          <mml:mi>\u2013<\/mml:mi>\n                          <mml:mn>382<\/mml:mn>\n                          <mml:mo>\u00d7<\/mml:mo>\n                          <mml:msup>\n                            <mml:mn>10<\/mml:mn>\n                            <mml:mn>9<\/mml:mn>\n                          <\/mml:msup>\n                          <mml:mi>\/<\/mml:mi>\n                          <mml:mi>L<\/mml:mi>\n                          <mml:mo stretchy=\"true\" form=\"postfix\">)<\/mml:mo>\n                        <\/mml:mrow>\n                      <\/mml:mrow>\n                    <\/mml:math>\n                    , and a new right bundle branch block (RBBB) with modest troponin elevation. Peripheral smear revealed D\u00f6hle bodies, vacuolated neutrophils, and giant platelets. Respiratory viral panel and blood cultures were negative. Polymerase chain reaction (PCR) confirmed\n                    <jats:italic>A. phagocytophilum<\/jats:italic>\n                    . The patient was initially treated empirically with atovaquone and azithromycin for presumed babesiosis, but therapy was narrowed to doxycycline with rapid recovery of symptoms and normalization of laboratory abnormalities. No echocardiogram or repeat electrocardiogram was performed during hospitalization despite the new conduction abnormality and elevated troponin, limiting conclusions regarding causality. This case underscores the need for heightened clinical suspicion in endemic regions, highlights an unusual severity of thrombocytopenia, and raises questions regarding potential cardiac involvement after the incidental finding of a new right bundle branch block.\n                  <\/jats:p>","DOI":"10.56305\/001c.158385","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:51:32Z","timestamp":1775062292000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe Thrombocytopenia and New Right Bundle Branch Block in Human Granulocytic Anaplasmosis: A Case Report"],"prefix":"10.56305","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8418-8529","authenticated-orcid":false,"given":"Zachary","family":"Shaw","sequence":"first","affiliation":[{"name":"Brown University Health","department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7065-7946","authenticated-orcid":false,"given":"Cynthia","family":"Zheng","sequence":"additional","affiliation":[{"name":"Brown University Health","department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"35509","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3390\/microorganisms10071433","article-title":"Human Granulocytic Anaplasmosis-A Systematic Review of Published Cases","volume":"10","author":"I. Dumic","year":"2022","journal-title":"Microorganisms"},{"issue":"16","key":"ref2","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1001\/jama.2016.2884","article-title":"Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review","volume":"315","author":"E. Sanchez","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"ref3","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3201\/eid1112.050898","article-title":"Human granulocytic anaplasmosis and Anaplasma phagocytophilum","volume":"11","author":"J. S. Dumler","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"ref4","doi-asserted-by":"publisher","first-page":"e0012313","DOI":"10.1371\/journal.pntd.0012313","article-title":"Human granulocytotropic anaplasmosis-A systematic review and analysis of the literature","volume":"18","author":"S. Schudel","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1196\/annals.1374.042","article-title":"Clinical diagnosis and treatment of human granulocytotropic anaplasmosis","volume":"1078","author":"J. S. Bakken","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"ref6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.idc.2015.02.007","article-title":"Human granulocytic anaplasmosis","volume":"29","author":"J. S. Bakken","year":"2015","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"ref7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.emc.2024.01.004","article-title":"Tick-Borne Diseases","volume":"42","author":"W. Eilbert","year":"2024","journal-title":"Emerg Med Clin North Am"},{"issue":"3","key":"ref8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7326\/M14-1589","article-title":"Platelet transfusion: a clinical practice guideline from the AABB","volume":"162","author":"R. M. Kaufman","year":"2015","journal-title":"Ann Intern Med"},{"issue":"3","key":"ref9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1200\/JCO.2017.76.1734","article-title":"Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"36","author":"C. A. Schiffer","year":"2018","journal-title":"J Clin Oncol"},{"issue":"5","key":"ref10","doi-asserted-by":"publisher","first-page":"CD004269","DOI":"10.1002\/14651858.CD004269.pub3","article-title":"Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation","volume":"2012","author":"L. Estcourt","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","article-title":"Anaplasmosis: epidemiology and statistics","author":"Centers for Disease Control and Prevention"},{"issue":"1","key":"ref12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cll.2009.10.004","article-title":"Human ehrlichiosis and anaplasmosis","volume":"30","author":"N. Ismail","year":"2010","journal-title":"Clin Lab Med"},{"issue":"26","key":"ref13","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1182\/blood-2016-09-693655","article-title":"How I evaluate and treat thrombocytopenia in the intensive care unit patient","volume":"128","author":"A. Greinacher","year":"2016","journal-title":"Blood"},{"issue":"1","key":"ref14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1186\/s13071-019-3852-6","article-title":"A review on the eco-epidemiology and clinical management of human granulocytic anaplasmosis and its agent in Europe","volume":"12","author":"I. A. Matei","year":"2019","journal-title":"Parasit Vectors"},{"issue":"9","key":"ref15","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"G. P. Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ref16","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/vetsci8120312","article-title":"Epidemiology, diagnosis, and dontrol of canine infectious cyclic thrombocytopenia and granulocytic anaplasmosis: emerging diseases of veterinary and public health significance","volume":"8","author":"F. A. Atif","year":"2021","journal-title":"Vet Sci"},{"issue":"12","key":"ref17","doi-asserted-by":"publisher","first-page":"8209","DOI":"10.1128\/IAI.73.12.8209-8218.2005","article-title":"Anaplasma phagocytophilum delay of neutrophil apoptosis through the p38 mitogen-activated protein kinase signal pathway","volume":"73","author":"K. S. Choi","year":"2005","journal-title":"Infect Immun"},{"issue":"4","key":"ref18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2217\/fca-2023-0028","article-title":"Acute myopericarditis due to human granulocytic anaplasmosis","volume":"19","author":"W. Rzechorzek","year":"2023","journal-title":"Future Cardiol"},{"issue":"1","key":"ref19","doi-asserted-by":"publisher","first-page":"ytad026","DOI":"10.1093\/ehjcr\/ytad026","article-title":"Case report: human granulocytic anaplasmosis causes acute myopericarditis with atrial fibrillation","volume":"7","author":"A. M. Levy","year":"2023","journal-title":"Eur Heart J Case Rep"},{"issue":"10","key":"ref20","doi-asserted-by":"publisher","first-page":"C8","DOI":"10.1111\/j.1525-1497.2005.0218_4.x","article-title":"Human granulocytic anaplasmosis affecting the myocardium","volume":"20","author":"A. Malik","year":"2005","journal-title":"J Gen Intern Med"},{"key":"ref21","series-title":"Arthropod Borne Diseases","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-13884-8_15","article-title":"Anaplasmosis","author":"F. Dantas-Torres","year":"2017"}],"container-title":["Journal of Brown Hospital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bhm.scholasticahq.com\/article\/158385-severe-thrombocytopenia-and-new-right-bundle-branch-block-in-human-granulocytic-anaplasmosis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:51:33Z","timestamp":1775062293000},"score":1,"resource":{"primary":{"URL":"https:\/\/bhm.scholasticahq.com\/article\/158385-severe-thrombocytopenia-and-new-right-bundle-branch-block-in-human-granulocytic-anaplasmosis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.56305\/001c.158385","relation":{},"ISSN":["2994-5593"],"issn-type":[{"value":"2994-5593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}